Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2007, p. 1563-1565, Vol. 51, No. 4
0066-4804/07/$08.00+0 doi:10.1128/AAC.01326-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Sequella, Inc., Rockville, Maryland 20850,1 Central Research Institute for Tuberculosis, Moscow 107564, Russia2
Received 24 October 2006/ Returned for modification 27 November 2006/ Accepted 13 January 2007
Substitution of the new diamine antibiotic SQ109 for ethambutol in a mouse model of chronic tuberculosis (TB) improved efficacy of combination drug therapy with first-line TB drugs rifampin and isoniazid, with or without pyrazinamide: at 8 weeks, lung bacteria were 1.5 log10 lower in SQ109-containing regimens.
Published ahead of print on 22 January 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»